Measles and rubella combined vaccine (Beijing Minhai Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles and rubella combined vaccine (Beijing Minhai Biotechnology)
Drug Alias NameLyophilised live attenuated measles and rubella combined vaccine - Beijing Minhai BiotechnologyMR attenuated combined vaccine - Beijing Minhai Biotechnology
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMeasles
Global Approved IndicationsRubellaMeasles
Approved Indications in ChinaRubellaMeasles
Original Approved Country/TerritoryMainland China
Original Approved Date2012/10/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsRubellaMeasles
Inactive IndicationsN/A

Other Information

ATC CodeJ07BD53
Related LinksN/A